Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine

ENGLISH
|
JAPANESE
|
CONNECT WITH US:

Nov 30, 2022 09:31 JST

Source: Eisai

Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer's Disease in the New England Journal of Medicine

TOKYO, Nov 30, 2022 - (JCN Newswire) - Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai's large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) and mild AD (collectively known as early AD) with confirmed presence of amyloid pathology in the brain, were published in the New England Journal of Medicine, one of the world's most prestigious peer-reviewed medical journals. For the details of the paper, please refer to: www.nejm.org/doi/full/10.1056/NEJMoa2212948.

The rapid publication of the Clarity AD study results demonstrates Eisai's strong commitment to trust and transparency based on Eisai's human health care mission. Eisai and Biogen remain committed to disclosing data and information on lecanemab. If approved, we will work to bring the drug expeditiously to people living with early AD and their families.

Eisai serves as the lead of lecanemab development and regulatory submissions globally with both Eisai and Biogen co-commercializing and co-promoting the product and Eisai having final decision-making authority.

This release discusses investigational uses of an agent in development and is not intended to convey conclusions about efficacy or safety. There is no guarantee that such an investigational agent will successfully gain health authority approval.

For more information, visit www.eisai.com/news/2022/pdf/enews202284pdf.pdf.

Source: Eisai
Sectors: BioTech

Copyright ©2026 JCN Newswire. All rights reserved. A division of Japan Corporate News Network.

Latest Release

Mitsubishi Motors

Mitsubishi Motors Launches the Xforce in Malaysia
Apr 08, 2026 20:47 JST

Mitsubishi Heavy Industries, Ltd.

MHI and Algomatic Win Second Place in the NEDO GENIAC-PRIZE Program
Apr 08, 2026 12:03 JST

Mitsubishi Heavy Industries, Ltd.

MHI Receives Contract for Renewal of APM System ATL SkyTrain at Hartsfield-Jackson Atlanta International Airport
Apr 07, 2026 16:42 JST

Mitsubishi Corporation

JFE Holdings and Mitsubishi Corporation Sign Second MOU to Advance Integrated Power and Data Center Project in Ohgishima, Keihin District
Apr 06, 2026 14:27 JST

NEC Corporation

Transgene and NEC Bio Sign License Agreement to Prepare the Next Steps of the Development of TG4050 in Head and Neck Cancer
Apr 03, 2026 12:33 JST

Hitachi, Ltd.

Hitachi Rail announces agreement to acquire Clever Devices, marking its growth as a global digital mobility player
Apr 03, 2026 11:09 JST

OMRON Corporation

OMRON Healthcare and UCSF launch AFib trial
Apr 03, 2026 00:00 JST

Denso

DENSO and FoodVentures Strengthen Collaboration through Capital Partnership in the Agricultural Sector

Apr 02, 2026 19:56 JST

Sharp Corporation

JRC, SKY Perfect JSAT, and Sharp Collaborate to Promote the Ministry of Defense's Publicly Announced Project "Development and Demonstration of Resiliency Technology for Multi-Orbit Communications Systems" Selected for JRC
Apr 02, 2026 16:01 JST

Mitsubishi Heavy Industries, Ltd.

MHIEC Completes Construction of Nanbu Relay Center for Nagasaki Prefecture's Ken'ou-Kennan Clean Authority
Apr 02, 2026 14:57 JST

HighTide Therapeutics Inc.

Moving Beyond the 'Blockbuster' Legacy to Reshape Kidney Disease Treatment Through a Dual-Mechanism Approach: Dialogue with HighTide Therapeutics' CMO Dr. Filip Surmont
Apr 02, 2026 12:00 JST

Mazda

Mazda EZ-6/Mazda6e Wins 2026 World Car Design of the Year Award
Apr 02, 2026 11:47 JST

Honda Motor Co, Ltd

Honda Makes Gachaco a Consolidated Subsidiary by Subscribing to New Shares of Gachaco Issued Through Third-party Allotment

Apr 01, 2026 22:09 JST

Denso

DENSO Hosted "DENSO DIALOG DAY 2026", Delivers Mid-Term Management Plan "CORE 2030"
Apr 01, 2026 21:54 JST

Mitsubishi Heavy Industries, Ltd.

MHI President Eisaku Ito Offers Words of Encouragement to New Employees at the Company's 2026 Welcoming Ceremony
Apr 01, 2026 13:35 JST

Mitsubishi Heavy Industries, Ltd.

MHI Completes the Transfer Procedures for its Domestic Onshore Wind Power Business
Apr 01, 2026 13:26 JST

Toyota Motor Corporation

Toyota Motor Corporation aims to join Daimler Truck and Volvo Group as equal shareholder in the fuel cell joint venture cellcentric
Mar 31, 2026 23:39 JST

Honda Motor Co, Ltd

Honda Announces the Establishment of PathAhead Co., Ltd., a Startup Originated from IGNITION, a Honda New Business Creation Program
Mar 31, 2026 21:58 JST

Hitachi, Ltd.

Hitachi Digital Services Strengthens OT-IT Integration with Manufacturing Operations Management Platform
Mar 31, 2026 19:14 JST

Fujitsu and Osaka University of Health and Sport Sciences partner to innovate sports performance with skeleton recognition AI
Mar 31, 2026 17:42 JST

More Latest Release >>